Zhixiong Zhang

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Engineered Nestin+ TSPC-Derived Exosomes Promote Tendon Repair Via Metabolic Reprogramming.

Engineered Nestin+ TSPC-Derived Exosomes Promote Tendon Repair Via Metabolic Reprogramming.

Journal: Journal of extracellular vesicles

Published: January 23, 2026

A systematic review and meta-analysis of cancer risk in patients with abdominal aortic aneurysm.

A systematic review and meta-analysis of cancer risk in patients with abdominal aortic aneurysm.

Journal: Journal of vascular surgery

Published: January 10, 2026

Exercise-induced popliteal artery compression due to a popliteal fossa cyst.

Exercise-induced popliteal artery compression due to a popliteal fossa cyst.

Journal: Journal of vascular surgery cases and innovative techniques

Published: January 02, 2026

Discovery of STING antagonists targeting cGAS-STING pathway to alleviate IMQ-induced psoriasis-like dermatitis.

Discovery of STING antagonists targeting cGAS-STING pathway to alleviate IMQ-induced psoriasis-like dermatitis.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: November 27, 2024

Exploration of the Performance and Mechanism of Uranium Adsorption by a Covalent Organic Framework Possessing the Thiazole Structure.

Exploration of the Performance and Mechanism of Uranium Adsorption by a Covalent Organic Framework Possessing the Thiazole Structure.

Journal: Langmuir : the ACS journal of surfaces and colloids

Published: November 03, 2023

New hope for tumor immunotherapy: the macrophage-related "do not eat me" signaling pathway.

New hope for tumor immunotherapy: the macrophage-related "do not eat me" signaling pathway.

Journal: Frontiers in pharmacology

Published: May 25, 2023

FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma.

FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma.

Journal: Journal of hematology & oncology

Published: October 24, 2022

Recent progress in DNA methyltransferase inhibitors as anticancer agents.

Recent progress in DNA methyltransferase inhibitors as anticancer agents.

Journal: Frontiers in pharmacology

Published: October 17, 2022

Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy.

Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy.

Journal: Journal of medicinal chemistry

Published: March 21, 2022

MiR-181a-5p Alleviates the Inflammatory Response of PC12 Cells by Inhibiting High-Mobility Group Box-1 Protein Expression.

MiR-181a-5p Alleviates the Inflammatory Response of PC12 Cells by Inhibiting High-Mobility Group Box-1 Protein Expression.

Journal: World neurosurgery

Published: February 18, 2022

Back on the scene: Advances and challenges in CD3-related drugs in tumor therapy.

Back on the scene: Advances and challenges in CD3-related drugs in tumor therapy.

Journal: Drug discovery today

Published: September 10, 2021

The X-ray structure of tubulysin analogue TGL in complex with tubulin and three possible routes for the development of next-generation tubulysin analogues.

The X-ray structure of tubulysin analogue TGL in complex with tubulin and three possible routes for the development of next-generation tubulysin analogues.

Journal: Biochemical and biophysical research communications

Published: May 14, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026